Nakamura N, Fusamoto H, Koizumi T
Acta Hepatogastroenterol (Stuttg). 1975 Apr;22(2):78-84.
Aminoacetonitrile (AAN) and its derivative, p-carboxyphenylglycyl-aminoacetonitrile (p-CPGAAN) were given to rats with chronic liver injury induced by carbon tetrachloride and their effects of the components of the hepatic connective tissue were studied. 1. Both AAN and p-CPGAAN markedly inhibited an increase in the amount of collagen in injured liver and in addition these agents interferred with an increase in the amount of hepatic glycosaminoglycans, particularly of the sulfated fraction. 2. In the AAN-treated group, such side effects attributable to AAN as loss of the body weight, depilation and exostosis were observed and an increase in the hepatic collagen solubility was also noted. However, no apparent side effect was found in the p-CPGAAN-treated group, and there was no difference in the solubility profile of hepatic collagen between the p-CPGAAN-treated and control groups. 3. It is assumed that p-CPGAAN has an action to prevent the hepatic fibrosis via a mechanism different from that of the lathyrogenic action.
将氨基乙腈(AAN)及其衍生物对羧基苯基甘氨酰 - 氨基乙腈(p - CPGAAN)给予由四氯化碳诱导的慢性肝损伤大鼠,并研究它们对肝结缔组织成分的影响。1. AAN和p - CPGAAN均显著抑制损伤肝脏中胶原蛋白量的增加,此外,这些药物还干扰了肝糖胺聚糖量的增加,特别是硫酸化部分。2. 在AAN治疗组中,观察到AAN引起的体重减轻、脱毛和外生骨疣等副作用,并且还注意到肝胶原蛋白溶解度增加。然而,在p - CPGAAN治疗组中未发现明显的副作用,并且p - CPGAAN治疗组和对照组之间肝胶原蛋白的溶解度曲线没有差异。3. 推测p - CPGAAN通过与致纤维化作用不同的机制具有预防肝纤维化的作用。